Advertisement Article continues below this ad Across several votes, the panelists voted 8-6, with one abstention, in favor of putting the peptides on FDAs list of substances considered safe for pharmacy compounding
A 2011 study by Ilic and colleagues in Life Sciences reported that BPC-157 at 10 g/kg or 10 ng/kg i.p
Safety Considerations for Injured Individuals While peptides like BPC 157 and TB 500 appear promising, they are not without risks: Side effects reported include nausea, headaches, dizziness, and injection-site reactions
Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The three essentials for running any reconstituted injectable: cold storage, accurate syringes, and metabolic tracking
minimise freeze-thaw cycles
